ONC201/TIC10 enhances durability of mTOR inhibitor everolimus in metastatic ER+ breast cancer.
| Autor: | Farmaki, Elena, Nath, Aritro, Emond, Rena, Karimi, Kimya L., Grolmusz, Vince K., Cosgrove, Patrick A., Bild, Andrea H. |
|---|---|
| Zdroj: | eLife; 9/29/2023, p1-21, 21p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|